Trial Profile
An Open-label, Randomized, Phase IIIB, Multicenter Trial to Evaluate the Pharmacodynamic Parameters of Intubation Bolus, and Bolus and Infusion Maintenance Doses of Zemuron in Pediatric and Adolescent Subjects
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Rocuronium bromide (Primary) ; Rocuronium bromide (Primary)
- Indications Anaesthesia
- Focus Therapeutic Use
- Sponsors Merck Sharp & Dohme; Merck Sharp & Dohme Corp.; NV Organon
- 27 Jan 2017 New trial record